4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-16-089486
CIK 0001411158operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:33 PM ET
Size
8.8 KB
Accession
0001209191-16-089486
Insider Transaction Report
Form 4
IPPOLITO VINCENT P
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2016-01-04$110.76/sh−100$11,076→ 71,740 total - Sale
Common Stock
2016-01-04$112.21/sh−555$62,278→ 71,185 total - Sale
Common Stock
2016-01-04$113.24/sh−200$22,648→ 70,985 total
Footnotes (3)
- [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person to cover taxes associated with the vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.89 to $112.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.98 to $113.495, inclusive.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 9:33 PM ET
- Size
- 8.8 KB